IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Abbott to Expand API Manufacturing Site in Ireland

2:32 AM MST | February 15, 2012 | Deepti Ramesh

Abbott Laboratories (Chicago, IL) says it will invest €85 million ($111 million) to expand its pharmaceutical manufacturing operations at Sligo, Ireland. The manufacturing facility at Sligo manufactures active pharmaceutical ingredients (APIs) as well as finished drug products. The expansion of the facility will be completed in 2014. The expansion will provide additional space for manufacturing operations to support Abbott’s future pharmaceutical pipeline in the therapeutic areas of virology, oncology and nephrology. The investment will result in the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa